Treatment of gastro‐oesophageal reflux disease with rabeprazole in primary and secondary care: does <scp>Helicobacter pylori</scp> infection affect proton pump inhibitor effectiveness?

Abstract

The effectiveness of rabeprazole in gastro-oesophageal reflux disease is not affected by the presence of H. pylori infection.